Dallas, TX - The poor response of systemic onset juvenile idiopathic arthritis (SoJIA) to TNF inhibitors and most other interventions appears to be the result of interleukin (IL)-1 overexpression in ...

First-line treatment with anakinra (an interleukin-1 receptor antagonist), results in a "good" clinical response in patients newly diagnosed with systemic onset juvenile idiopathic arthritis, and ...

Previous studies had indicated that treatments for the rare condition known as VEXAS were either not very effective or came with major side effects. Interleukin-1 inhibitors are among the treatments ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “SARS-CoV-2 is thought to bind to toll-like receptors, ...

New treatment options and rapid progress in understanding of juvenile idiopathic arthritis (JIA) pathophysiology led the American College of Rheumatology (ACR) to update its 2011 recommendations on ...

Senior woman wearing mask infected by coronavirus on hospital bed receiving medicine by drip. Close-up fingers of the senior patient ´s hand while she is sleeping. Horizontal photo Authors of a ...

The FDA has issued an emergency use authorization (EUA) for anakinra (Kineret) injection for the treatment of COVID-19 in certain hospitalized adults. These patients include those with pneumonia who ...

Please provide your email address to receive an email when new articles are posted on . Steroids are commonly used to mitigate severe treatment-related adverse events associated with chimeric antigen ...

A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill coronavirus disease 2019 (COVID-19) ...